{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:00:20Z","timestamp":1791608420198,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":5668,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1111\/j.1538-7836.2007.02562.x","type":"journal-article","created":{"date-parts":[[2007,5,26]],"date-time":"2007-05-26T11:32:24Z","timestamp":1180179144000},"page":"1115-1124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Treatment of severe von Willebrand disease with a high\u2010purity von Willebrand factor concentrate (Wilfactin\u00ae): a prospective study of 50 patients"],"prefix":"10.1016","volume":"5","author":[{"given":"A.","family":"BOREL\u2010DERLON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"FEDERICI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"ROUSSEL\u2010ROBERT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"GOUDEMAND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"SCHARRER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"ROTHSCHILD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"BERNTORP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"HENRIET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"TELLIER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"BRIDEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"MANNUCCI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0010","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0015","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0020","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20\u2003years","volume":"20","author":"Mannucci","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.1992.tb01159.x","article-title":"Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate","volume":"62","author":"Burnouf\u2010Radosevich","year":"1992","journal-title":"Vox Sang"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2141.1992.tb08903.x","article-title":"Clinical and biological evaluation in von Willebrand disease of a von Willebrand factor concentrate with low factor VIII activity","volume":"80","author":"Goudemand","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00001721-199304060-00018","article-title":"Biological effects of S\/D\u2010treated, very high purity, von Willebrand factor concentrate in five patients with severe von Willebrand disease","volume":"4","author":"Meriane","year":"1993","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl.3","key":"10.1111\/j.1538-7836.2007.02562.x_bb0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2516.1998.0040s3048.x","article-title":"Clinical management of patients with von Willebrand disease with a VHP vWF concentrate: the French experience","volume":"4","author":"Goudemand","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.0042-9007.2004.00398.x","article-title":"In vitro study of a triple\u2010secured von Willebrand factor concentrate","volume":"86","author":"Mazurier","year":"2004","journal-title":"Vox Sang"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1538-7836.2005.01435.x","article-title":"Pharmacokinetic studies on Wilfactin\u00ae, a von Willebrand factor concentrate with a low factor VIII content treated with three virus inactivation\/removal methods","volume":"3","author":"Goudemand","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2007.02562.x_bb0055","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/01.mbc.0000167658.85143.49","article-title":"Management of von Willebrand disease with factor VIII\/von Willebrand factor concentrates: results from current studies and surveys","volume":"16","author":"Federici","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0060","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1351-8216.2003.00816.x","article-title":"Successful treatment of urgent bleeding in von Willebrand disease with factor VIII\/VWF concentrate (Humate\u2010P\u00ae): use of ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy","volume":"9","author":"Cox Gill","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V99.2.450","article-title":"Treatment of von Willebrand disease with a high\u2010purity factor VIII\/von Willebrand factor concentrate: a prospective, multicenter study","volume":"99","author":"Mannucci","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1351-8216.2003.00809.x","article-title":"Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII\/VWF concentrate (Humate\u2010P\u00ae)","volume":"10","author":"Thompson","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0075","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/01.mbc.0000167659.23262.18","article-title":"Long\u2010term prophylaxis in von Willebrand disease","volume":"16","author":"Berntorp","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0080","doi-asserted-by":"crossref","first-page":"507a","DOI":"10.1182\/blood.V106.11.1782.1782","article-title":"Secondary long\u2010term prophylaxis in severe patients with von Willebrand disease: an Italian cohort study","volume":"106","author":"Federici","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V57.1.25.25","article-title":"Precipitating antibodies to factor VIII\/von Willebrand Factor in von Willebrand Disease: effect on replacement therapy","volume":"57","author":"Mannucci","year":"1981","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/1040-8428(94)90040-X","article-title":"Molecular, cellular and clinical aspects of parvovirus infection","volume":"16","author":"Brown","year":"1994","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.seminhematol.2004.09.009","article-title":"von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis","volume":"42","author":"Martinelli","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0037-1613225","article-title":"Venous thromboembolism in von Willebrand disease","volume":"88","author":"Mannucci","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand\u2019s disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02562.x_bb0120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613227","article-title":"Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand disease","volume":"88","author":"Makris","year":"2002","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02562.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362210231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362210231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02562.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:41:10Z","timestamp":1761532870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362210231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S153878362210231X"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02562.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of severe von Willebrand disease with a high\u2010purity von Willebrand factor concentrate (Wilfactin\u00ae): a prospective study of 50 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02562.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}